Form 4: Vita Coco CEO Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Vita Coco's CEO, Martin Roper, executed multiple sales of common stock under a pre-arranged 10b5-1 trading plan, both directly and through family trusts.
Summary
- Martin Roper, the CEO of Vita Coco Company, Inc., sold a total of 40,000 shares of common stock across multiple transactions on December 3rd and 4th, 2024.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan.
- The shares were sold at weighted average prices ranging from approximately $35.29 to $36.25 per share.
- Some of the shares were sold directly by Mr. Roper, while others were sold through family trusts associated with his children: Christopher G. Roper, Peter S. Roper, and Thomas L. Roper.
- Mr. Roper also holds a significant number of non-qualified stock options with various vesting schedules and exercise prices.
Sentiment
Score: 5
Explanation: The document is neutral in sentiment. It reports on routine stock sales by an executive under a pre-arranged plan. There is no indication of positive or negative news about the company's performance.
Risks
- The sale of shares by the CEO could be perceived negatively by some investors, potentially impacting the stock price.
- The use of a 10b5-1 trading plan suggests pre-planned sales, but the timing could still raise questions.
Industry Context
Executive stock sales are a common occurrence, and the use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading. The impact on the stock price will depend on market sentiment and the overall performance of the company.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the beverage industry such as Coca-Cola (KO) and PepsiCo (PEP).
- The volume of shares sold by Mr. Roper is not unusual for a CEO, and the prices are within the typical range for market transactions.
- The vesting schedules of the stock options are also typical for executive compensation packages.
Stakeholder Impact
- Shareholders may react to the stock sales, potentially impacting the stock price in the short term.
- The sales do not directly impact employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 12/03/2024 | Date of the first set of stock sales by Martin Roper and family trusts. |
| 12/04/2024 | Date of the second set of stock sales by Martin Roper and family trusts. |
| 12/05/2024 | Date of the filing of the Form 4. |
| 09/19/2029 | Expiration date of one of the non-qualified stock options. |
| 01/11/2031 | Expiration date of one of the non-qualified stock options. |
| 10/21/2031 | Expiration date of one of the non-qualified stock options. |
| 03/10/2033 | Expiration date of one of the non-qualified stock options. |
| 03/04/2034 | Expiration date of one of the non-qualified stock options. |
Keywords
Vita Coco, Martin Roper, stock sale, 10b5-1 trading plan, insider trading, executive compensation, share transactions, family trusts, stock options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.